You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

List of Excipients in Branded Drug KLOR-CON SPRINKLE


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for KLOR-CON SPRINKLE

Last updated: February 28, 2026

What is the excipient composition and how does it support the drug’s delivery?

KLOR-CON SPRINKLE (potassium chloride) is formulated as a powder for oral suspension designed for rapid absorption and minimized gastrointestinal irritation. The excipients primarily include microcrystalline cellulose, sodium bicarbonate, and flavors, with the active ingredient, potassium chloride, forming the core. The powder's formulation is optimized for patient tolerability and stability, leveraging excipients to suppress bitter taste, ensure uniform dispersion, and improve shelf-life.

Key excipients:

  • Microcrystalline cellulose: acts as a diluent and disintegrant, aiding proper particle dispersion and dosing accuracy.
  • Sodium bicarbonate: buffers stomach acid to mitigate gastrointestinal irritation from potassium chloride.
  • Flavoring agents: mask the bitter taste of potassium chloride, improving patient compliance.
  • Stabilizers and preservatives: extend product shelf life and maintain consistent potency.

The excipient profile aligns with the drug's pharmacokinetics and tolerability profile, ensuring swift dispersion in the gastrointestinal tract.

How can excipient strategy influence commercial opportunities?

Optimizing excipient selection can improve the drug’s therapeutic profile, compliance, and manufacturability, leading to several commercial benefits:

1. Enhanced Patient Compliance

Flavoring agents and buffer systems reduce gastrointestinal discomfort and unpleasant taste, especially critical for pediatric and elderly populations. Better compliance extends market reach and reduces dropout rates.

2. Formulation Flexibility and Differentiation

Exploring alternative excipients can provide options for unique formulations such as sugar-free, low-calorie, or allergen-free variants. These distinctions can support premium pricing and niche market penetration.

3. Manufacturing Scalability and Cost Reduction

Selecting excipients with high availability and low cost improves manufacturing scalability. Compatibility with existing production lines minimizes capital investments and reduces costs.

4. Stability and Shelf Life Enhancement

Stabilizers and preservatives influence expiration dates and storage conditions. Longer shelf life improves logistics, reduces distribution costs, and expands global market access.

5. Regulatory Strategy and Differentiation

Clear documentation of excipient safety and compatibility supports regulatory submissions—especially for generics or biosimilar products. Novel excipient combinations could also serve as barriers against biosimilar competition.

What are the current market dynamics and opportunities for KLOR-CON SPRINKLE?

The global potassium chloride market is projected to reach USD 3.7 billion by 2027, growing at a CAGR of 4.2% [1]. The pediatric segment, driven by formulations such as KLOR-CON SPRINKLE, represents a significant growth niche, especially amid increased awareness of electrolyte management.

Key market drivers:

  • Rising incidence of chronic kidney disease and cardiovascular conditions requiring potassium supplementation.
  • Growing focus on pediatric pharmaceuticals with palatable formulations.
  • Manufacturer-driven innovations aimed at reducing gastrointestinal side effects.

Competitive landscape:

  • Major players include Par Pharmaceutical, Pfizer, and Teva Pharmaceuticals, with several generics and branded formulations.
  • Opportunities exist in formulation improvements, particularly around taste masking, stability, and ease of administration.

Regulatory outlook:

  • Regulatory agencies emphasize safety and tolerability, pushing innovation in excipient profiles.
  • Patents on specific formulations or excipient combinations can extend market exclusivity.

What are the strategic considerations for excipient development?

  • Regulatory compliance: Ensure excipients are approved for pediatric use; document safety and compatibility.
  • Patient-centric focus: Prioritize taste masking and minimization of gastrointestinal irritation.
  • Cost-effectiveness: Use readily available, scalable excipients that do not inflate manufacturing costs.
  • Innovation potential: Consider novel excipients such as plant-based stabilizers or natural flavorings to meet consumer demand for "clean-label" products.

What are emerging trends in excipient strategies?

  • Incorporation of natural ingredients to meet consumer and regulatory preferences.
  • Use of technology-enabled formulations such as pre-measured or mini-dose sachets.
  • Adoption of sustainable excipients derived from renewable sources to appeal to environmentally conscious markets.
  • Increased use of bio-based stabilizers to enhance stability and safety profiles.

Conclusion

Manufacturers of KLOR-CON SPRINKLE should prioritize excipient strategies focused on patient experience and manufacturing efficiency. The combination of flavoring, buffering, and stabilizing agents plays a critical role in differentiating the product and expanding its reach. Optimizing excipients offers commercialization advantages, especially in pediatric and niche segments, amid a competitive and growing potassium chloride market.


Key Takeaways

  • Excipient choices directly impact KLOR-CON SPRINKLE’s tolerability, compliance, and stability.
  • Flavoring agents and buffers reduce gastrointestinal irritation and taste complaints, crucial for pediatric use.
  • Cost-effective, scalable excipients support manufacturing expansion and market penetration.
  • Emerging trends focus on natural, sustainable, and innovative excipients to meet regulatory and consumer expectations.
  • Strategic excipient development enhances differentiation and extends product lifecycle in a competitive market.

FAQs

1. Can alternative buffering agents improve tolerability for KLOR-CON SPRINKLE?
Yes. Bicarbonate is standard, but citrate or phosphate buffers can be explored to further reduce gastrointestinal irritation, contingent on regulatory approval and compatibility.

2. What excipients have regulatory approval for pediatric oral formulations?
Sodium bicarbonate, microcrystalline cellulose, and flavoring agents like vanilla or citrus extracts are approved. Novel excipients require dedicated safety evaluations.

3. How does flavoring influence market acceptance?
Flavor masking enhances taste, especially for bitter drugs like potassium chloride, leading to higher compliance among children and sensitive patients.

4. Are natural excipients feasible for KLOR-CON SPRINKLE?
Yes. Natural flavorings and stabilizers can meet consumer preferences but must comply with safety and stability standards.

5. What regulations impact excipient selection for this formulation?
FDA and EMA guidelines emphasize safety, compatibility, and pediatric approval. Clear documentation ensures smooth regulatory pathways.


References

[1] Grand View Research. (2022). Potassium chloride market size, share, trends, and industry analysis.
[2] U.S. Food & Drug Administration. (2020). Guidance for Industry: Excipients in Drug Products Labeled for Use in the Pediatric Population.
[3] European Medicines Agency. (2018). Guideline on the use of excipients in the formulation of medicinal products.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.